Breadcrumb

[A05-19A] Cholinesterase inhibitors in Alzheimer's disease

Overview

Overview

Commission: Commission awarded on 2005-02-22 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Final report  [PDF, 2 MB]Further documents
Contact address:to the contact form
Linked projects: [A09-05] Cholinesterase inhibitors in Alzheimer's disease - supplementary commission: rivastigmine patches and galantamine
Status: Commission completed

[A09-03] Update search on Report A05-19A (cholinesterase inhibitors in the treatment of Alzheimer's Disease) - Rapid report
Status: Commission completed


Report documents

Report documents

PublishedDocumentSizeType 
2007-04-10 Executive summary of the final report 53 kBPDFdownload file
2007-04-10 Final report 2 MBPDFdownload file
2006-09-08 Preliminary report (German version) 3 MBPDFdownload file
2006-06-20 Amendment 1 to the report plan version 1.0 (German version) 37 kBPDFdownload file
2005-07-12 Report plan version 1.0 (German version) 84 kBPDFdownload file


At a glance

Accompanying information

Executive summary of the final report

  File-Icon  Cholinesterase inhibitors in Alzheimer´s disease [PDF, 53 kB]

Health information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealthonline.org.

How effective are cholinesterase inhibitors?

Press releases

2009-09-10 Alzheimer’s disease: only a few therapies provide proof of benefit to patients

2007-04-10 Cholinesterase inhibitors can slightly delay the deterioration of cognitive function



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close